Literature DB >> 6986745

The occurrence of hyperaldosteronism in infants with congestive heart failure.

B G Baylen, G Johnson, R Tsang, L Srivastava, S Kaplan.   

Abstract

Serum aldosterone and plasma renin were measured in 20 normal infants and 15 infants with congestive cardiac failure. Serum aldosterone was significantly increased (151 +/- 38 ng/dl mean +/- standard error of the mean) in patients before treatment when compared with aldosterone in normal infants (29 +/- 7 ng/dl). Increasing serum aldosterone was related to increasing plasma renin. The response to furosemide appeared to be inversely related to serum aldosterone concentrations. In four infants, administration of an aldosterone antagonist (spironolactone) resulted in improved diuresis and decreased serum aldosterone. Hyperaldosteronism is an important factor contributing to fluid and sodium retention in infants with heart failure.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6986745     DOI: 10.1016/0002-9149(80)90650-5

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

Review 1.  New drug approaches to the treatment of heart failure in infants and children.

Authors:  S Kaplan
Journal:  Drugs       Date:  1990-03       Impact factor: 9.546

2.  Urinary aldosterone excretion and electrolytic balance in response to chronic diuretic therapy in very low-birth weight infants.

Authors:  S Costa; F Cota; C Romagnoli; C Latella; L Maggio; F Gallini
Journal:  J Endocrinol Invest       Date:  2010-11-08       Impact factor: 4.256

Review 3.  ACE inhibitors in pediatric patients with heart failure.

Authors:  Kazuo Momma
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

4.  Inhibition of angiotensin converting enzyme with enalapril maleate in infants with congestive heart failure.

Authors:  J P Dutertre; E M Billaud; E Autret; A Chantepie; I Oliver; J Laugier
Journal:  Br J Clin Pharmacol       Date:  1993-05       Impact factor: 4.335

Review 5.  Use of diuretics in the neonatal period.

Authors:  Jean-Pierre Guignard; Silvia Iacobelli
Journal:  Pediatr Nephrol       Date:  2021-01-22       Impact factor: 3.714

6.  Model-Informed Optimization of a Pediatric Clinical Pharmacokinetic Trial of a New Spironolactone Liquid Formulation.

Authors:  Manasa Tatipalli; Vijay Kumar Siripuram; Tao Long; Diana Shuster; Galina Bernstein; Pierre Martineau; Kim A Cook; Rodrigo Cristofoletti; Stephan Schmidt; Valvanera Vozmediano
Journal:  Pharmaceutics       Date:  2021-06-08       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.